Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Massachusetts › Boston
Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Boston, MA keessatti
Qorannoo 11 Kansera Urothelial (Cell Transitional) f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #7, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
- Tufts Medical Center, Boston
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- Massachusetts General Hospital, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Dana Farber Cancer Institute, Boston
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Dana-Farber Cancer Institute, Boston
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Dana Farber Cancer Institute, Boston
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Namoota walitti qabaa jiraQorannoo ilaalaa
- Dana-Farber Cancer Institute, Boston
Sacituzumab Govitecan Plus EV in Metastatic UC
Namoota walitti qabaa jiraSadarkaa 1/2
- Dana Farber Cancer Institute, Boston
Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti
- Nashville, TNQorannoo 23
- New York City, NYQorannoo 22
- Dallas, TXQorannoo 18
- Edison, NJQorannoo 18
- Houston, TXQorannoo 18
- Los Angeles, CAQorannoo 17
- Queens, NYQorannoo 15
- Chicago, ILQorannoo 14
- Arlington, VAQorannoo 12
- San Antonio, TXQorannoo 11
- Austin, TXQorannoo 10
- Orange, CAQorannoo 10
Qorannoo biroo Boston keessatti
- Saree OljooQorannoo 111
- Kansara Qara'a Non-Small CellQorannoo 90
- Saree (Gosoota Hunda)Qorannoo 86
- Kansarii ColorectalQorannoo 63
- Kansara MetastatikiiQorannoo 63
- Dhibee QaraQorannoo 62
- Kansarii OvariiQorannoo 61
- Kansarii ProstateQorannoo 59
- DepreshiniiQorannoo 52
- Kansa EndometiriyaaliiQorannoo 50
- Cufama OnneeQorannoo 44
- Leukemia Myeloidii HamaaQorannoo 44
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.